Relievant Medsystems
Relievant Medsystems, based in Edina, Minnesota, offers the Intracept Procedure, a minimally invasive treatment for chronic vertebrogenic low back pain, now accessible to over 68 million patients due to endorsements from major insurers.
Services
Relievant Medsystems offers the Intracept Procedure, a minimally invasive treatment designed for chronic vertebrogenic low back pain. This same-day, outpatient procedure uses targeted radiofrequency energy to ablate the basivertebral nerve, providing pain relief while preserving the overall structure of the spine. The Intracept Procedure is notable for being implant-free, adding to its appeal as a treatment option.
Clinical Trials
The Intracept Procedure offered by Relievant Medsystems is supported by two Level I randomized clinical trials. These trials validate the effectiveness and safety of the procedure, ensuring that it meets rigorous scientific and medical standards. The strong clinical evidence underpins the company's commitment to providing effective treatment for chronic low back pain.
Insurance Coverage
Relievant Medsystems has received positive coverage policies from major insurance providers like Humana, Anthem Blue Cross and Blue Shield, and Noridian Healthcare Solutions. This extended coverage facilitates access to the Intracept Procedure for over 68 million patients, making the treatment widely available to those in need.
Headquarters and Facilities
Relievant Medsystems is headquartered in Edina, Minnesota, with a state-of-the-art development and operations facility located in Sunnyvale, California. These strategic locations support the company's operational needs and drive its mission to innovate in the field of spinal healthcare.
Patient Impact
The Intracept Procedure has treated over 15,000 patients, demonstrating its efficacy and acceptance within the medical community. This significant number reflects the growing trust and reliance on Relievant Medsystems' solutions for chronic vertebrogenic low back pain.